Leidos (LDOS) director boosts deferred stake with 305 dividend-equivalent shares
Rhea-AI Filing Summary
Leidos Holdings director reports additional stock units from dividend equivalents. A Leidos Holdings, Inc. (LDOS) director filed a statement of beneficial ownership covering a transaction dated 12/31/2025. The filing shows an acquisition of 305.0167 shares of common stock at a price of $0, credited through dividend equivalent rights under a Key Executive Stock Deferral Plan. After this transaction, the director beneficially owned 128,639.4827 shares indirectly through the deferral plan and 91,360 shares directly. The dividend equivalent rights noted in the explanation indicate the award reflects dividends on previously deferred equity, rather than an open-market stock purchase.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 305.017 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Leidos Holdings (LDOS) report in this Form 4?
The Form 4 reports that a Leidos Holdings, Inc. director acquired 305.0167 shares of common stock on 12/31/2025 at a price of $0, credited under a Key Executive Stock Deferral Plan.
Is the reporting person in the Leidos (LDOS) Form 4 an officer or a director?
The filing identifies the reporting person’s relationship to Leidos Holdings, Inc. as a Director, with no officer title indicated.
How are the indirect Leidos (LDOS) holdings structured for this director?
The indirect holdings of 128,639.4827 shares are held through a Key Executive Stock Deferral Plan, as indicated in the ownership table.
Does this Leidos (LDOS) Form 4 include any derivative securities transactions?
The section for derivative securities is present, but the provided content shows no specific derivative securities acquired or disposed of in this filing.